Reducing the risk of hepatitis B virus transfusion-transmitted infection

References

• ZaaijerHLVrielinkKootMEarly detection of hepatitis B surface antigen and detection of HbsAg mutants: a comparison of five assaysVox Sang200181421922111903996
   PubMed Web of Science ®Google Scholar
• WeberBDenglerTBergerADoerrHWRabenauHEvaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection. IMMULITE HBsAg and IMMULITE 2000 HBsAgJ Clin Microbiol200341113514312517838
   PubMed Web of Science ®Google Scholar
• MizuochiTOkadaKUmemoriKMizusawaSSatoSYamaguchiKReactivity of genotypically distinct hepatitis B virus surface antigen in ten commercial diagnostics kits available in JapanJpn J Infect Dis2005582838715858285
   PubMed Web of Science ®Google Scholar
• World Health OrganizationBlood products and related biologicals Available at: http://www.who.int/bloodproducts/en/. Accessed 2011 Jun 29.
   Google Scholar
• MoermanBMoonsVSommerHSchmittYStetterMEvaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assaysClin Lab2004503–415916215074469
   PubMedGoogle Scholar
• OlingerCMWeberBOtegbayoJAAmmerlaanWvan der Taelem-BruléNMullerCPHepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S geneMed Microbiol Immunol2007196424725217503077
   PubMed Web of Science ®Google Scholar
• StramerSLPooled HBV DNA testing by nucleic acid amplification: implementation or not?Transfusion20054581242124616078908
   PubMed Web of Science ®Google Scholar
• BiswasRTaborEHsiaCCComparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infectionTransfusion200343678879812757531
   PubMed Web of Science ®Google Scholar
• SeedCRChengAIsmaySLVirology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood ServiceAssessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implication for future HBV NATTransfusion200242101365137212423522
   PubMed Web of Science ®Google Scholar
• OffergeldRHamoudaOBurgerREpidemiological data – an important part of the hemovigilance systemTransfusion Med Hemother2010373125130
   Web of Science ®Google Scholar
• ThiersVNakajimaEKremsdorfDTransmission of hepatitis B from hepatits-B-seronegative subjectsLancet198828623127312762904005
   PubMed Web of Science ®Google Scholar
• KanekoSMillerRHFeinstoneSMDetection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assayProc Natl Acad Sci U S A19898613123162643103
   PubMed Web of Science ®Google Scholar
• MarcellinPMartinot-PeignouxMLoriotMAPersistence of hepatitis B Virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapyAnn Intern Med199011232272282297196
   PubMed Web of Science ®Google Scholar
• BlumHELiangTJGalunEWandsJRPersistence of hepatitis B viral DNA after serological recovery form hepatitis B virus infectionHepatology199114156632066074
   PubMed Web of Science ®Google Scholar
• LoriotMAMarcellinPBismuthEDemonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAG to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis BHepatology199215132361727796
   PubMed Web of Science ®Google Scholar
• FongTLDi BisceglieAMGerberMAWaggonerJGHoofnagleJHPersistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis BHepatology1993186131313188244254
   PubMed Web of Science ®Google Scholar
• MichalakTIPasquinelliCGuilhotSChisariFVHepatitis B virus persistence after recovery from acute viral hepatitisJ Clin Invest1994942907 Erratum for J Clin Invest. 1994;93:230–239.8040346
   PubMed Web of Science ®Google Scholar
• ZhangYHanssonBGKuoLSWidellANordenfeltEHepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAgHepatology19931745385447682978
   PubMed Web of Science ®Google Scholar
• RehermannBFerrariCPasquinelliCChisariFVThe hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of cytotoxic T-lymphocyte responseNat Med1996210110411088837608
   PubMed Web of Science ®Google Scholar
• SaraswatSBanerjeeKChaudhuryNPost-transfusion hepatitis type B following multiple transfusions of HBsAg-negative bloodJ Hepatology1996255639643
   Web of Science ®Google Scholar
• MasonALXuLGuoLKuhnsMPerrilloRPMolecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigenHepatology1998276173617429620351
   PubMed Web of Science ®Google Scholar
• SilvaAEMcMahonBJParkinsonAJSjogrenMHHoofnagleJHDi BisceglieAMHepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccineClin Infect Dis19982648958979564471
   PubMed Web of Science ®Google Scholar
• SaitoTShinzawaHUchidaTQuantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis BJ Med Virol199958432533110421397
   PubMed Web of Science ®Google Scholar
• WangJTLeeCZChenPJWangTHChenDSTransfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriersTransfusion200242121592159712473140
   PubMed Web of Science ®Google Scholar
• AllainJPOccult hepatitis B infection: implication in transfusionVox Sang2004862839115023176
   PubMed Web of Science ®Google Scholar
• ColemanPFChenYCMushahwarIKImmunoassay detection of hepatitis B surface antigen mutantsJ Med Virol1999591192410440803
   PubMed Web of Science ®Google Scholar
• IrelandJHO’DonnellBBasuniAAReactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assaysHepatology20003151176118210796895
   PubMed Web of Science ®Google Scholar
• WeberBMelchiorWGehrkeRDoerrHWBergerARabenauHHepatitis B virus markers in anti-HBc only positive individualsJ Med Virol200164331231911424120
   PubMed Web of Science ®Google Scholar
• JeantetDCheminIMandrandBCloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assaysJ Med Virol200473450851515221893
   PubMed Web of Science ®Google Scholar
• WeberBThe diagnostic and clinical impact of the genetic variability of the S (surface) gene of hepatitis B virusJ Lab Med2004285659
   Google Scholar
• WeberBGenetic variability of the S gene of hepatitis B virus: clinical and diagnostic impactJ Clin Virol200532210211215653412
   PubMed Web of Science ®Google Scholar
• JongeriusJMWesterMCuypersHTNew hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assaysTransfusion199838156599482395
   PubMed Web of Science ®Google Scholar
• Levicnik-StezinarSHepatitis B surface antigen escape mutant in a first-time blood donor potentially missed by a routine screening assayClin Lab2004501–2495115000220
   PubMedGoogle Scholar
• NiederhauserCWeingandTCandottiDFatal outcome of a hepatitis B virus transfusion-transmitted infectionVox Sang201098450450720070649
   PubMed Web of Science ®Google Scholar
• HsuHYChangMHNiYHChenHLSurvey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in TaiwanGut200453101499150315361503
   PubMed Web of Science ®Google Scholar
• TheamboonlersAChongsrisawatVJantaradsameePPoovorawanYVariants within the “a” determinant of HBs gene in children and adolescent with a without hepatitis B vaccination as part of Thailand’s Expanded Program on Immunization (EPI)Tohoku J Exp Med2001193319720511315767
   PubMed Web of Science ®Google Scholar
• Joller-JemelkaHIWickiANGrobPJDetection of HBs antigen in “anti-HBc alone” positive seraJ Hepatol19942122692727989721
   PubMed Web of Science ®Google Scholar
• ZhangJMXuYWangXYCoexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infectionClin Infect Dis20074491161116917407033
   PubMed Web of Science ®Google Scholar
• Japanese Red Cross Non–A Hepatitis Research GroupEffect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitisLancet19913388774104010411681356
   PubMed Web of Science ®Google Scholar
• KojimaMShimizuMTsuchimochiTPostransfusion fulminant hepatitis B associated with precore-defective HBV mutantsVox Sang199160134392053327
   PubMed Web of Science ®Google Scholar
• HughesWBarrADowBCFollettEABarbaraJAA multicentre assessment of the specificity of ten anti-HBc screening assaysTransfus Med1995532252308593528
   PubMed Web of Science ®Google Scholar
• California Blood Bank SocietyHomepage on the Internet AABB TTD Report March 2004. Available from: http://www.cbbsweb.org/hotopics/hotopics_2004.html. Accessed 2011 Jun 29.
   Google Scholar
• SchmidtMNüblingCMScheiblauerHAnti-HBc screening of blood donors: a comparison of nine anti-HBc testsVox Sang200691323724316958836
   PubMed Web of Science ®Google Scholar
• AokiSKFinegoldDKuramotoIKSignificance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccineTransfusion19933353623678488537
   PubMed Web of Science ®Google Scholar
• StramerSLAnti-HBc testing and donor re-entryBlood Products Advisory Committee MeetingOctober 2004 Available at: http://www.fda.gov/ohrms/dockets/ac/05/slides/5-4190S1_5b.ppt. Accessed 2011 Jun 29.
   Google Scholar
• RothWKSeifriedEThe German experience with NATTransfus Med200212425525812220254
   PubMed Web of Science ®Google Scholar
• FlanaganPCharlewoodGHorderSDrawitskyMHollisHReducing the risk of transfusion transmitted hepatitis B in New ZealandVox Sang200589Suppl S223 [abstr 4PS-11-03]
   Google Scholar
• NiederhauserCTaleghaniBMGrazianiMStolzMTinguelyCSchneiderPBlood donor screening: how to decrease the risk of transfusion transmitted hepatitis B Virus?Swiss med Wkly20081389–1013414118330733
   PubMed Web of Science ®Google Scholar
• CandottiDAllainJPTransfusion-transmitted hepatitis B virus infectionJ Hepatology2009514798809
   Web of Science ®Google Scholar
• RothWKWeberMPetersenDNAT for HBV and anti-HBC testing increase blood safetyTransfusion200242786987512375659
   PubMed Web of Science ®Google Scholar
• KleinmanSHKuhnsMCToddDSfor the Retrovirus Epidemiology Donor StudyFrequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screeningTransfusion200343669670412757519
   PubMed Web of Science ®Google Scholar
• MarusawaHUemotoSHijikataMLatent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigenHepatology200031248849510655275
   PubMed Web of Science ®Google Scholar
• HassMHannounCKalininaTSommerGManegoldCGuntherSFunctional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individualsHepatology20054219310315962285
   PubMed Web of Science ®Google Scholar
• AllainJPInternational collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screeningVox Sang200792325425717348876
   PubMed Web of Science ®Google Scholar
• RothWKHepatitis and blood transfusionISBT Science Series20072178183
   Google Scholar
• SatoSOhhashiWIharaHSakayaSKatoTIkedaHComparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assayTransfusion20014191107111311552066
   PubMed Web of Science ®Google Scholar
• YoshikawaAGotandaYItabashiMMinegishiKNishiokaKthe Japanese Red Cross NAT Screening Research GroupHBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNAVox Sang2005882778615720604
   PubMed Web of Science ®Google Scholar
• YoshikawaAGotandaYItabashiMMinegishiKKanemitsuKNishiokaKthe Japanese Red Cross NAT Screening Research Grouphepatitis B NAT virus-positive [corrected] blood donors in the early and late stages of HBV infection: analysis of the WP and kinetics of HBV DNAVox Sang20058827786 Erratum in Vox Sang. 2005;88(3):223.15720604
   PubMed Web of Science ®Google Scholar
• MatsumotoCTadokoroKFujimuraKHirakawaSMitsunagaSJujiTAnalysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repositoryTransfusion200141787888411452155
   PubMed Web of Science ®Google Scholar
• DreierJKrögerMDiekmannJGöttingCKleesiekKLow-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donorTransfus Med20041429710315113374
   PubMed Web of Science ®Google Scholar
• GerlichWHBreakthrough of hepatitis B virus escape mutants after vaccination and virus reactivationJ Clin Virol200636Suppl 1S18S2216831688
   PubMed Web of Science ®Google Scholar
• SatakeMTairaRYugiHInfectivity of blood components with low hepatitis B virus DNA levels identified in a lookback programTransfusion20074771197120517581154
   PubMed Web of Science ®Google Scholar
• GrobPJilgWBornhakHSerological pattern “anti-HBc alone”: report on a WorkshopJ Med Virol200062445045511074473
   PubMed Web of Science ®Google Scholar
• BrojerEGrabarczykPLiszewskiGMikulskaMAllainJPLetowskaMPolish Blood Transfusion Service Viral Study Group. Characterization of HBV DNA +/HBsAg- blood donors in Poland identified by triplex NATHepatology20064461666167417133474
   PubMed Web of Science ®Google Scholar
• VelatiCRomanoLFomiattiLBaruffiLZanettiARSIMTI Research GroupImpact of nucleic acid testing for hepatitis B virus, hepatitis C virus and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year surveyTransfusion200848102205221318631163
   PubMed Web of Science ®Google Scholar
• MargaritisARBrownSMSeedCRKielyPD’AgostinoBKellerAJComparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNATransfusion200747101783179317880602
   PubMed Web of Science ®Google Scholar
• NantachitNThaikrueaLThongsawatSEvaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern ThailandTransfusion200747101803180817880604
   PubMed Web of Science ®Google Scholar
• LiLChenPJChenMHVhakKFLinKSTsaiSJA pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for Hepatitis C virusTransfusion20084861198120618422856
   PubMed Web of Science ®Google Scholar
• VermeulenMLelieNSykesWImpact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South AfricaTransfusion20094961115112519309474
   PubMed Web of Science ®Google Scholar
• AllainJPHewittPETedderRSWilliamsonLMEvidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusionBr J Haematol1999107118619510520040
   PubMed Web of Science ®Google Scholar
• BurgerROffergeldRTesting plasma donations for hepatitis B core antigen (anti-HBc) in order to improve safety of cellular blood components and of quarantined fresh frozen plasmaBundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz2005486698699 German.
   Google Scholar
• ReesinkHWEngelfrietCPHennGOccult hepatitis B infection in blood donorsVox Sang200894215316618205672
   PubMed Web of Science ®Google Scholar
• StolzMTinguelyCGrazianiMEfficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low endemic regionTransfusion201050122695270620573074
   PubMed Web of Science ®Google Scholar
• TabuchiATanakaJKatayamaKTitration of hepatitis B virus infectivity in the sera of pre-acute and late-acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytesJ Med Virol200880122064206819040280
   PubMed Web of Science ®Google Scholar
• JilgWSiegerEZachovalRSchätzlHIndividuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virusJ Hepatol199523114208530804
   PubMed Web of Science ®Google Scholar
• CardosoMSKoernerKKubanekBMini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus and HIV: preliminary resultsTransfusion199838109059079767739
   PubMed Web of Science ®Google Scholar
• TomonoTthe Japanese Red Cross NAT Screening ResearchStatus of NAT Screening for HCV, HIV and HBV: experience in JapanBrownFSeitzRAdvances in transfusion safetyKarger, BaselDevelopments in Biologicals Verlag;20012939
   Google Scholar
• MinegishiKYoshikawaAKishimotoSJapanese Red Cross NAT Screening Research Group. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screeningVox Sang200384428729112757502
   PubMed Web of Science ®Google Scholar
• BuschMPShould HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?Transfus Clin Biol2004111263214980546
   PubMed Web of Science ®Google Scholar
• KuhnsMCKleinmanSHMcNamaraALRawalBGlynnSBuschMPLack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implication for future HBV screening policyTransfusion20044491332133915318857
   PubMed Web of Science ®Google Scholar
• KleinmanSStrongDMTegmeierGHepatitis B (HBV) DNA screening of blood donation in minipools with the COBAS AmpliScreen HBV testTransfusion20054581247125716078909
   PubMed Web of Science ®Google Scholar
• AllainJPCandottiDSoldanKThe risk of hepatitis B virus infection by transfusion in Kumasi, GhanaBlood200310162419242512393691
   PubMed Web of Science ®Google Scholar
• KielyPStewartYCastroLAnalysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor managementTransfusion200343558459012702178
   PubMed Web of Science ®Google Scholar
• El EkiabyMAllainJPLinnenJLelieNHepatitis B virus DNA and hepatitis B surface antigen concentrations in Egyptian blood donors: limits of detection of ultrasensitive nucleic acid screening tests in HBsAg carriers [abstract]Vox Sang200996Suppl 12A-S04S021718
   Google Scholar
• PennaAArtiniMCavalliALong-lasting memory T cell responses following self-limited acute Hepatitis BJ Clin Invest1996985118511948787682
   PubMed Web of Science ®Google Scholar
• YotsuyanagiHYasudaKIinoSPersistent viremia after recovery from self-limited acute hepatitis BHepatology1998275137713829581694
   PubMed Web of Science ®Google Scholar
• BrechotCThiersVKremsdorfDNalpasBPolSPaterlini-BrechotPPersistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”?Hepatology200134119420311431751
   PubMed Web of Science ®Google Scholar
• AlhababiFSallamTATongCYThe significance of anti-HBc only in the clinical virology laboratoryJ Clin Virol200327216216912829038
   PubMed Web of Science ®Google Scholar
• BuschMPPrevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testingVox Sang199874Suppl 21471549704438
   PubMed Web of Science ®Google Scholar
• DoddRYReesinkHWBuschMPISBT international forum: do surrogate tests improve the safety of the blood supply?Vox Sang19956932802918578747
   PubMed Web of Science ®Google Scholar
• AntarWEl-ShokryMHAbd El HamidWAHelyMFSignificance of detecting anti-HBc among Egyptian male blood donors negative for HBsAgTransfus Med201020640941320573069
   PubMed Web of Science ®Google Scholar
• GlynnSAKleinmaSHWrightDJBuschMPfor the REDS groupInternational application of the incidence rate/window period modelTransfusion200242896697212385404
   PubMed Web of Science ®Google Scholar
• CandottiDGrabarczykPGhiazzaPCharacterization of occult hepatitis B virus form blood donors carrying genotype A2 or genotype D strainsJ Hepatol200849453754718602718
   PubMed Web of Science ®Google Scholar
• CandottiDAllainJPTransfusion-transmitted hepatitis B virus infectionJ Hepatol200951479880919615780
   PubMed Web of Science ®Google Scholar
• DowBCPeterkinMAGreenRHACameronSOHepatitis B virus transmission by blood donation negative for hepatitis B surface antigen, antibody to HBsAg, antibody to hepatitis core antigen and HBV DNAVox Sang200181214011555478
   PubMed Web of Science ®Google Scholar
• ManziniPGirottoMBorsottiRItalian blood donors with anti-HBc and occult hepatitis B virus infectionHaematologica200792121664167018055990
   PubMed Web of Science ®Google Scholar
• ManziniPAbateMLValpredaCEvidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donorTransfusion200949475776419171000
   PubMed Web of Science ®Google Scholar
• HoofnagleJHSeefeLBBalesZBZimmermannHJType B hepatitis after transfusion with blood containing antibody to hepatitis B core antigenN Engl J Med19782982513791383652005
   PubMed Web of Science ®Google Scholar
• MosleyJWStevensCEAachRDDonor screening for antibody to hepatitis core antigen and hepatitis B virus infection in transfusion recipientsTransfusion19953515127998069
   PubMed Web of Science ®Google Scholar
• ElghouzziMHCourouceAMMagniusLOLunelFLapierreVTransmission of hepatitis B virus by HBV-negative blood transfusionLancet199534689809647564744
   PubMed Web of Science ®Google Scholar
• Levicnik-StezinarSRahne-PotokarUCandottiDLelieNAllainJPAnti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipientsJ Hepatol20084861022102518436328
   PubMed Web of Science ®Google Scholar
• HollingerFBHepatitis B virus infection and transfusion medicine: science and the occultTransfusion20084851001102618454738
   PubMed Web of Science ®Google Scholar
• TegtmeierGHendersonSMcNamaraAKuhnsMContribution of anti-HBc screening to blood safety at a regional blood center in the United States [abstract]Transfusion1997Suppl 3711S
   Google Scholar
• KomiyaYKatayamaKYugiHMinimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype CTransfusion200848228629418028278
   PubMed Web of Science ®Google Scholar
• YugiHHinoSSatakeMTadodoroKImplementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in JapanVox Sang200589426516262762
   PubMed Web of Science ®Google Scholar
• YugiHMizuiMTanakaJYoshizawaHHepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing – Japanese experienceJ Clin Virol200636Suppl 1S56S6416831695
   PubMed Web of Science ®Google Scholar
• TadokoroKThe new Japanese blood law: its impact on blood safety and usageDev Biol (Basel)200712716116817486889
   PubMedGoogle Scholar
• ComanorLHollandPHepatitis B virus blood screening: unfinished agendaVox Sang200691111216756595
   PubMed Web of Science ®Google Scholar
• HenningHPuchtaILuhmJSchlenkePGeorgSKirchnerHFrequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis core antigenBlood200210072637264112239179
   PubMed Web of Science ®Google Scholar
• ChevrierMCSt-LouisMPerreaultJDetection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid assayTransfusion200747101794180217880603
   PubMed Web of Science ®Google Scholar
• O’BrienSYiQ-LFanWScaliaVKleinmanSHVamvakasECCurrent incidence and estimated resiudal risk of transfusion-transmitted infections in donations made to Canadian Blood ServicesTransfusion200747231632517302779
   PubMed Web of Science ®Google Scholar
• HourfarMKJorkCSchottstedtVGerman Red Cross NAT Study GroupExperience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virusTransfusion20084881558156618466173
   PubMed Web of Science ®Google Scholar
• LinautsSSaldanaJStrongDMPRISM HBsAg detection of hepatitis B virus minipool nucleic acid testing yield samplesTransfusion20084871376138218422847
   PubMed Web of Science ®Google Scholar
• StramerSLCurrent risk of transfusion-transmitted agents: a reviewArch Pathol Lab Med2007131570270717488155
   PubMed Web of Science ®Google Scholar
• StramerSLWendUCandottiDNucleic acid testing to detect HBV infection in blood donorsN Engl J Med2011364323624721247314
   PubMed Web of Science ®Google Scholar
• MineHEmuraHMiyamotoMHigh throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitits C virus and human immunodeficiency virus type-1 by nucleic acid amplification tewting with specific and sensitive multiplex reagent in JapanJ Virol Methods20031121–214515112951223
   PubMed Web of Science ®Google Scholar
• RamiaSRamlawiFKanaanMKlymeSNamanRFrequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donorsEpidemiol Infect2005133469569916050516
   PubMed Web of Science ®Google Scholar
• KatsoulidouAMoschidisZSypsaVAnalytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral loadVox Sang200792181417181585
   PubMed Web of Science ®Google Scholar
• Owusu-OforiSTempleJSakrodieFAnokwaMCandottiDAllainJPPredonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settingsTransfusion200545213314015660820
   PubMed Web of Science ®Google Scholar
• SoedarmonoYSMSuyatiMFPurwatiLBArfatFNucleic acid testing of first time Indonesian blood donorsVox Sang200589Suppl S224 [abstract 4PS-11-05].
   Google Scholar
• WongILamSTeoDOverview of nucleic acid testing (NAT) on blood donations in SingaporeVox Sang2005891192615938736
   PubMed Web of Science ®Google Scholar
• MakrooRNChoudhuryNJagannathanLMulticenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 and hepatitis B and C viruses in Indian blood donorsIndian J Med Res20081714014718403791
   PubMed Web of Science ®Google Scholar
• PhikulsodSOotaSTirawatnapongTWorking Group for NAT Study in Thai Blood DonationsOne-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus and hepatitis B virus in Thai blood donationsTransfusion20094961126113519392770
   PubMed Web of Science ®Google Scholar
• WeustenJVermeulenMvan DrimmelenHLelieNRefinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithmsTransfusion201151120321520707858
   PubMed Web of Science ®Google Scholar
• KoppelmanMAssalAChuddyMMulticenter performance evaluation of a multiplex transcription mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA and hepatitis B virus DNA in blood donationsTransfusion20054581258126616078910
   PubMed Web of Science ®Google Scholar
• YotsuyanagiHYasudaKMoriyaKFrequent presence of HBV in the sera of HBsA-negative, anti-HBc positive blood donorsTransfusion20014191093109911552064
   PubMed Web of Science ®Google Scholar
• JacksonBRBuschMPStramerSLAuBuchonJPThe cost-effectivness of NAT for HIV, HCV and HBV in whole-blood donationsTransfusion200343672172912757522
   PubMed Web of Science ®Google Scholar
• DoddRYNotariEPStramerSLCurrent prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor populationTransfusion200242897597912385406
   PubMed Web of Science ®Google Scholar
• CosteJReesinkHWEngelfrietCPInternational forum. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003Vox Sang200588428930315877653
   PubMed Web of Science ®Google Scholar
• NiederhauserCSchneiderPFoppMRueferALévyGIncidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003Euro Surveill200510278
   Google Scholar
• OffergeldRFaensenDRitterSHamoudaOHuman immunodeficiency virus, hepatitis C and B infections among blood donors in Germany 2000–2002: risk of virus transmission and the impact of nucleic acid amplification testingEuro Surveill200510281115735310
   PubMedGoogle Scholar
• SoldanKDavisonKDowBEstimates of the frequency of HBV, HCV and HIV infectious donations entering the blood supply in the United Kindom, 1996 to 2003Euro Surveill2005102171915735312
   PubMedGoogle Scholar
• SeedCRKielyPKellerAJResidual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virusIntern Med J2005351059259816207258
   PubMed Web of Science ®Google Scholar
• LapercheSManiezMBarletVTransfusion-Transmissible Agents Working Group, French National Society of Blood TransfusionA revised method for estimatin hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident casesTransfusion200848112308231418673347
   PubMed Web of Science ®Google Scholar
• Center for Biologics Evaluation and ResearchBlood Products Advisory Committee, 94th MeetingGaithersburg, MDApril 1, 2009 (transcript). Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccine-sandOtherBiologics/BloodProductsAdvisoryCommittee/UCM155628.pdf. Accessed 2011 Jun 29.
   Google Scholar
• TostiMESolinasSPratiDAn estimate of the current risk of transmitting blood-borne infections through blood transfusion in ItalyBr J Haematol2002117121521911918558
   PubMed Web of Science ®Google Scholar
• ShangGSeedCRWangFNieDFarrugiaAResidual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004Transfusion200747352953917319836
   PubMed Web of Science ®Google Scholar
• Alvarez do BarrioMGonzalez DiezRHernandez SanchezJMOyonarte GomezSResidual risk of transfusion-transmitted viral infections in Spain, 1997– 2002, and impact of nucleic acid testingEuro Surveill2005102202215735311
   PubMedGoogle Scholar
• ZouSStramerSLNotariEPCurrent incidence and residual risk of hepatitis B infection among blood donors in the United StatesTransfusion20094981609162019413732
   PubMed Web of Science ®Google Scholar
• O’BrienSFXiGFanWEpidemiology of hepatitis B in Canada blood donorsTransfusion200848112323233018647366
   PubMed Web of Science ®Google Scholar
• DanielsDGrytalSWasleyASurveillance for acute viral hepatitis – United States, 2007MMWR Surveill Summ200958312719478727
   PubMedGoogle Scholar
• KleinmanSHBuschMPRisks transfusion transmitted infection: direct estimation and mathematical modellingBailleres Best Pract Res Clin Haematol2000134631649
   PubMed Web of Science ®Google Scholar
• KorelitzJJBuschMPKleinmanSKFor the National Heart Lung and Blood Institute Retrovirus Epidemiology Donor Study. A method for estimating hepatitis B virus incidence rates in volunteer donorsTransfusion19973766346409191825
   PubMed Web of Science ®Google Scholar
• KleinmanSHBuschMPAssessing the impact of HBV NAT on window period reduction and residual riskJ Clin Virol200636Suppl 1S23S2916831689
   PubMed Web of Science ®Google Scholar
• RaimondoGAllainJPBrunettoMRStatements from the Taormina expert meeting on occult hepatitis B virus infectionJ Hepatol200849465265718715666
   PubMed Web of Science ®Google Scholar
• YoshikawaAGotandaYMinegishiKJapanese Red Cross NAT Screening Research Group. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (HBsAg-negative) infection in the acute stageTransfusion20074771162117117581150
   PubMed Web of Science ®Google Scholar
• ChalmersTCKoffRSGradyGFA note on fatality in serum hepatitisGastroenterology1965492226
   Web of Science ®Google Scholar
• InabaSItoAMiyataYIndividual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusionTransfusion200646112028202917076860
   PubMed Web of Science ®Google Scholar
• GerlichWHWagnerFFChudyMHBsAg non-reactive HBV infection in blood donors: transmission and pathogenicityJ Med Virol200779S32S36
   Web of Science ®Google Scholar
• AachRDAlterHJHollingerFBRisk of transfusing blood containing antibody to hepatitits-B surface antigenLancet1974278741901934135609
   PubMed Web of Science ®Google Scholar
• ChangMWImpact of hepatitis B vaccination on hepatitis disease and nucleic acid testing in high-prevalence populationsJ Clin Virol200636Suppl 1S45S5016831693
   PubMed Web of Science ®Google Scholar
• NiYHHuangLMChangMHTwo decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategiesGastroenterology200713241287129317433322
   PubMed Web of Science ®Google Scholar
• NardoneAAnastassopoulouCGTheetenHA comparison of hepatitis B seroepidemiology in ten European countriesEpidemiol Infect2009137796196919102797
   PubMed Web of Science ®Google Scholar
• SinghHPradhanMSinghRLHigh frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusionsVox Sang200384429229912757503
   PubMed Web of Science ®Google Scholar
• PrinceAMLeeDHBrotmanBInfectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infectionTransfusion200141332933211274585
   PubMed Web of Science ®Google Scholar
• AlterHJHougthonMHepatitis C virus and elimination post transfusion hepatitisNat Med20006101082108611017126
   PubMed Web of Science ®Google Scholar
• HoofnagleJHPost-transfusion hepatitis BTransfusion19903053843862360228
   PubMed Web of Science ®Google Scholar